Amyloidosis and Crohn´s disease

Area of Science:

• Gastroenterology
• Nephrology
• Internal Medicine

Background:

• Secondary amyloidosis is a rare but serious complication of inflammatory bowel disease (IBD).
• Early diagnosis of secondary amyloidosis in IBD is increasing, but treatment remains challenging.
• This complication can significantly impact patient prognosis, potentially more than the underlying IBD.

Observation:

• Four cases of Crohn's disease (CD) with secondary amyloidosis were reported, representing 0.68% of CD patients in the studied health areas.
• No cases of amyloidosis were observed in patients with ulcerative colitis (UC).
• In the reported cases, secondary amyloidosis was strongly associated with fistulizing Crohn's disease.

Findings:

• The predominant clinical manifestation of amyloidosis in these patients was nephrotic syndrome.
• All patients showed improved renal function with a treatment regimen including medical and surgical management of Crohn's disease and colchicine.
• One patient with severe amyloidosis ultimately required a kidney transplant.

Implications:

• This case series highlights the significant association between Crohn's disease, particularly the fistulizing type, and secondary amyloidosis.
• The findings suggest that a multimodal treatment approach, including addressing the underlying CD and colchicine therapy, can be effective in managing amyloidosis-related renal dysfunction.
• Further research into optimal treatment strategies for secondary amyloidosis in IBD patients is warranted.